Condition: Intrahepatic Cholangiocarcinoma · Locally Advanced Intrahepatic Cholangiocarcinoma · Sponsor: Assistance Publique - Hôpitaux de Paris
The study hypothesis is that liver transplantation after selective internal radiation therapy (SIRT) and chemotherapy would improve 3-year overall survival in patients with locally advanced (unresectable but non-metastatic) intrahepatic cholangiocarcinoma. It is planned to include 36 patients with locally advanced intrahepatic cholangiocarcinoma, not eligible for initial surgery and without metastases. Participants will be recruited from care facilities in France.
This description comes directly from the study's public registry record.
Mohamed BOUATTOUR · 1.40.87.56.14 · mohamed.bouattour@aphp.fr
Always discuss trial participation with your own doctor first.
| Beaujon | Clichy-sous-Bois, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06910722